Search

Leo F Einck

age ~73

from McLean, VA

Get Report
Also known as:
  • Leo Dr Einck
  • Leo S Einck
Phone and address:
939 Dead Run Dr, Mc Lean, VA 22101
7033564063
Related to:
Connected to:

Leo Einck Phones & Addresses

  • 939 Dead Run Dr, McLean, VA 22101 • 7033564063 • 7038278912
  • Mc Lean, VA
  • Rockville, MD
  • Whiting, IA
  • Chevy Chase, MD
  • Grosse Ile, MI
  • Fairfax, VA
  • 939 Dead Run Dr, Mc Lean, VA 22101 • 7039158157

Work

  • Company:
    Sequella, inc.
    1998
  • Position:
    Cso

Education

  • Degree:
    Associate degree or higher

Skills

Biotechnology • Drug Discovery • Biopharmaceuticals • Technology Transfer • Infectious Diseases • Molecular Biology • Clinical Development • Immunology • Microbiology • Elisa • Clinical Trials • Lifesciences • Drug Development • Vaccines • Licensing • Strategic Planning • Pcr

Emails

l***[email protected]

Industries

Biotechnology
Name / Title
Company / Classification
Phones & Addresses
Leo Einck
Founder, President, Chief Scientific Officer, Founder / Chief Scientific Officer
Sequella Inc
Noncommercial Research Organization · All Other Support Svcs
9610 Med Ctr Dr, Rockville, MD 20850
9610 Medical Ctr Dr, Rockville, MD 20850
3017627776, 3017627778

Resumes

Leo Einck Photo 1

Chief Strategy Officer

view source
Location:
8531 west Howell Rd, Bethesda, MD 20817
Industry:
Biotechnology
Work:
Sequella, Inc. since 1998
CSO
Skills:
Biotechnology
Drug Discovery
Biopharmaceuticals
Technology Transfer
Infectious Diseases
Molecular Biology
Clinical Development
Immunology
Microbiology
Elisa
Clinical Trials
Lifesciences
Drug Development
Vaccines
Licensing
Strategic Planning
Pcr

Us Patents

  • Anti Tubercular Drug: Compositions And Methods

    view source
  • US Patent:
    7456222, Nov 25, 2008
  • Filed:
    Jul 1, 2005
  • Appl. No.:
    11/173192
  • Inventors:
    Marina Nikolaevna Protopopova - Silver Springs MD, US
    Richard Edward Lee - Cordova TN, US
    Richard Allan Slayden - Ft. Collins CO, US
    Elena Bogatcheva - Bethesda MD, US
    Leo Einck - McLean VA, US
  • Assignee:
    Sequella, Inc. - Rockville MD
    The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
  • International Classification:
    A61K 31/132
    A61K 31/135
    A61K 31/44
    A61K 31/445
  • US Classification:
    514648, 514306, 514317, 514649, 514653, 514654, 514655, 514659, 514660, 564316, 564320, 564355, 564366, 564368, 564369, 564370, 564453, 564454, 564455, 564457, 546134, 546194, 546246
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

  • Anti Tubercular Drug: Compositions And Methods

    view source
  • US Patent:
    7842729, Nov 30, 2010
  • Filed:
    Jun 3, 2005
  • Appl. No.:
    11/145499
  • Inventors:
    Marina Nikolaevna Protopopova - Silver Springs MD, US
    Richard Edward Lee - Cordova TN, US
    Richard Allan Slayden - Ft. Collins CO, US
    Elena Bogatcheva - Bethesda MD, US
    Leo Einck - McLean VA, US
  • Assignee:
    The United States of America as represented by the Department of Health and Human Services - Washington DC
    Sequella, Inc. - Rockville MD
  • International Classification:
    A61K 31/132
    A61K 31/135
    A61K 31/44
    A61K 31/445
  • US Classification:
    514648, 514306, 514317, 514649, 514653, 514654, 514655, 514659, 514660, 564316, 564320, 564355, 564366, 564368, 564369, 564370, 564453, 564454, 564455, 564457, 546134, 546194, 546246
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

  • Methods And Compositions For Determining The Pathogenic Status Of Infectious Agents

    view source
  • US Patent:
    7919234, Apr 5, 2011
  • Filed:
    Apr 7, 2008
  • Appl. No.:
    12/080929
  • Inventors:
    Matthew C. Mulvey - Baltimore MD, US
    Leo Einck - McLean VA, US
    Katherine Sacksteder - Baltimore MD, US
  • Assignee:
    Sequella, Inc. - Rockville MD
  • International Classification:
    C12Q 1/02
    C12Q 1/68
    C12Q 1/70
  • US Classification:
    435 5, 435 6, 435 29
  • Abstract:
    Methods and compositions for the detection of disease caused by infectious agents and microbes are provided. In particular, methods and compositions comprising novel combinations of nucleic acid amplification and drug susceptibility technologies are provided. In certain embodiments, the present invention enables the detection of infectious agents and microbes as well as providing information concerning the viability status of the agent or microbe. In one embodiment, the present invention is used for the detection of mycobacterial infections, including, but not limited to, tuberculosis.

  • Compositions And Methods For Treatment Of Infectious Disease

    view source
  • US Patent:
    8202910, Jun 19, 2012
  • Filed:
    Oct 22, 2008
  • Appl. No.:
    12/255976
  • Inventors:
    Marina Nikolaena Protopopova - Silver Spring MD, US
    Leo Einck - McLean VA, US
    Boris Nikonenko - Rockville MD, US
    Ping Chen - Bethesda MD, US
  • Assignee:
    Sequella, Inc. - Rockville MD
  • International Classification:
    A61K 31/132
    A61K 31/135
    A61K 31/44
    A61K 31/445
  • US Classification:
    514648, 514306, 514317, 514649, 514653, 514654, 514655, 514659, 514660, 564316, 564320, 564355, 564366, 564368, 564369, 564370, 564453, 564454, 564455, 564457, 546134, 546194, 546246
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis. In certain embodiments, the present invention comprises compositions comprising novel substituted ethylene diamine compounds further comprising antitubercular agents such as rifampicin, isoniazid, pyrazinamide and ethambutol.

  • Compositions And Methods For The Treatment Of Infectious Diseases

    view source
  • US Patent:
    8268894, Sep 18, 2012
  • Filed:
    Nov 11, 2010
  • Appl. No.:
    12/944231
  • Inventors:
    Marina Nikolaevna Protopopova - Silver Spring MD, US
    Elena Bogatcheva - Bethesda MD, US
    Leo Einck - McLean VA, US
    Richard Edward Lee - Cordova TN, US
    Richard Allan Slayden - Ft. Collins CO, US
  • Assignee:
    The United States of America as Represented by the Secretary, Department of Health and Human Services - Washington DC
    Sequella, Inc. - Rockville MD
  • International Classification:
    A61K 31/132
    A61K 31/135
    A61K 31/44
    A61K 31/445
  • US Classification:
    514648, 514306, 514317, 514649, 514653, 514654, 514655, 514659, 514660, 564316, 564320, 564355, 564366, 564368, 564369, 564370, 564453, 564454, 564455, 564457, 546134, 546194, 546246
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

  • Methods And Compositions For Determining The Pathogenic Status Of Infectious Agents

    view source
  • US Patent:
    8501400, Aug 6, 2013
  • Filed:
    Jan 21, 2011
  • Appl. No.:
    13/011754
  • Inventors:
    Matthew C. Mulvey - Baltimore MD, US
    Leo Einck - McLean VA, US
    Katherine Sacksteder - Baltimore MD, US
  • Assignee:
    Sequella, Inc. - Rockville MD
  • International Classification:
    C12Q 1/02
    C12Q 1/68
    C12Q 1/70
    C07H 21/02
    C12N 15/00
  • US Classification:
    435 5, 435 61, 435 29, 4353201
  • Abstract:
    The present invention relates to methods and compositions for improved detection of infectious agents and microbes. In particular, the present invention provides novel methods for detecting infectious agents, providing information about the viability status of such infectious agents and for determining drug susceptibility. In certain embodiments, the present invention employs techniques involving nucleic acid amplification-based microbial identification together with phage-based biological detection of drug resistance. The methods of the invention are suitable for all microbes and infectious agents, including bacterial agents such as.

  • Anti Tubercular Drug: Compostions And Methods

    view source
  • US Patent:
    20040019117, Jan 29, 2004
  • Filed:
    May 19, 2003
  • Appl. No.:
    10/441146
  • Inventors:
    Marina Protopopova - Silver Spring MD, US
    Richard Lee - Cordova TN, US
    Richard Slayden - Ft. Collins CO, US
    Clifton Barry - Washington DC, US
    Elena Bogatcheva - Bethesda MD, US
    Leo Einck - McLean VA, US
  • International Classification:
    A61K031/137
    A61K031/695
    A61K031/44
    A61K031/40
  • US Classification:
    514/649000, 514/063000, 514/357000, 514/408000
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

  • Anti Tubercular Drug: Compositions And Methods

    view source
  • US Patent:
    20040033986, Feb 19, 2004
  • Filed:
    May 16, 2003
  • Appl. No.:
    10/440017
  • Inventors:
    Marina Protopopova - Silver Springs MD, US
    Richard Lee - Cordova TN, US
    Richard Slayden - Ft. Collins CO, US
    Clifton Barry - Washington DC, US
    Elena Bogatcheva - Bethesda MD, US
    Leo Einck - McLean VA, US
  • International Classification:
    A61K031/695
    A61K031/44
    A61K031/137
  • US Classification:
    514/063000, 514/357000, 514/649000
  • Abstract:
    Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

Facebook

Leo Einck Photo 2

Leo Einck

view source
Get Report for Leo F Einck from McLean, VA, age ~73
Control profile